Growth Trends in Europe's Precision Medicine Software Market: Focus on Product Type, Application, End User, and Country - Analysis and Forecast, 2024-2033
December 19, 2024 06:20 ET
|
Research and Markets
Dublin, Dec. 19, 2024 (GLOBE NEWSWIRE) -- The "Growth Trends in Europe's Precision Medicine Software Market: Focus on Product Type, Application, End User, and Country - Analysis and Forecast,...
Whole Exome Sequencing Market Research Report 2024-2034: Growing Role in Bioinformatics, Precision Medicine for Oncology, Impacts of AI
December 18, 2024 07:11 ET
|
Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Whole Exome Sequencing Market - A Global and Regional Analysis: Focus on Product, Workflow, Application, End User, and Country - Analysis and Forecast,...
Artificial Intelligence (AI) in Drug Discovery Industry to Generate Revenues of $13.5 Billion in 2030 - Growing Use of AI for Drug Repurposing Expands Opportunities in Pharmaceutical Development
December 18, 2024 04:02 ET
|
Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
AI in Precision Medicine Market to Hit US$ 3.92 Billion by 2030 with 30.7% CAGR | MarketsandMarkets™.
December 17, 2024 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Delray Beach, FL, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The global AI in precision medicine market is projected to reach USD 3.92 billion by 2030 from USD 0.78 billion in 2024, at a CAGR of 30.7% from...
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
December 17, 2024 06:30 ET
|
Silexion Therapeutics Corp
Cayman Islands, December 17, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Growth Trends in the CRISPR and Cas Gene Market: Industry Opportunities and Strategies to 2028 & 2033
December 13, 2024 09:27 ET
|
Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Gene Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.This report describes and...
Precision Medicine Strategic Business Report 2024 - Growth of Direct-to-Consumer Genetic Testing Expands Opportunities for Precision Medicine in Preventive Healthcare - Forecasts to 2030
December 13, 2024 08:51 ET
|
Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Precision Medicine...
Optical Genome Mapping Industry Research (2018-2033) Featuring Profiles of Agilent Technologies, Illumina, PerkinElmer Genomics, Bio-Rad Labs, Qiagen and Other Leading Players
December 11, 2024 04:20 ET
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This report covers market...
Silexion Therapeutics Appoints Renowned Cancer Therapeutics Expert Prof. Amnon Peled to Board of Directors
December 10, 2024 08:30 ET
|
Silexion Therapeutics Corp
Cayman Islands, December 10, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Myriad Genetics’ Portfolio Elevated by Updated NCCN Prostate Cancer Guidelines
December 10, 2024 08:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics’ full suite of urologic oncology products is elevated by updated NCCN prostate cancer guidelines.